Assessing readmission databases: How reliable is the information?

Journal of Arthroplasty

Volumn 27, Issue 8 SUPPL., 2012, Pages

  Keeney, James A ^a   Adelani, Muyibat A ^a   Nunley, Ryan M ^a   Clohisy, John C ^a   Barrack, Robert L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health care policy; Readmission databases; Total hip or total knee arthroplasty

Indexed keywords

AGED; ARTICLE; DATA BASE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL RECORD; MEDICAL RECORD REVIEW; POSTOPERATIVE HEMORRHAGE; PROSTHESIS INFECTION; RELIABILITY; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

EID: 84865354386     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2012.03.032     Document Type: Article

References (16)

1. Prosser G.H., Yates P.J., Wood D.J., et al. Outcome of primary resurfacing hip replacement: evaluation of risk factors for early revision. Acta Orthop 2010, 81:66.
2. Conroy J.L., Whitehouse S.L., Graves S.E., et al. Risk factors for revision for early dislocation in total hip arthroplasty. J Arthroplasty 2008, 23:867.
3. Katz J.N., Barrett J., Mahomed N.N., et al. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 2005, 86:1909.
4. Katz J.N., Losina E., Barrett J., et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am 2001, 83:1622.
5. Vorhies J.S., Wang Y., Herndon J., et al. Readmission and length of stay after total hip arthroplasty in a national medicare sample. J Arthroplasty 2011, in press.
6. Huddleston J.I., Wang Y., Uguillas C., et al. Age and obesity are risk factors for adverse events after total hip arthroplasty. Clin Orthop Relat Res 2012, 470:490.
7. Pedersen A.B., Sorensen H.T., Mehnert F., et al. Risk factors for venous thromboembolism in patient undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am 2010, 92:2156.
8. Espehaug B., Engesaeter L.B., Vollset S.E., et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997, 79:590.
9. Auerbach A. Healthcare quality measurement in orthopaedic surgery: current state of the art. Clin Orthop Rel Res 2009, 467:2542.
10. Bozic K.J., Chiu V.W., Takemoto S.K., et al. The validity of using administrative claims data in total joint arthroplasty outcomes research. J. Arthroplasty 2010, 25(6 Suppl):58.
11. Weaver F., Hynes D., Hopkinson W., et al. Preoperative risks and outcomes of hip and knee arthroplasty in the Veterans Health Administration. J Arthroplasty 2003, 18:693.
12. Mahomed N.N., Barrett J.A., Katz J.N., et al. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am 2003, 85:27.
13. Mahomed N.N., Barrett J., Katz J.N., et al. Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am 2005, 87:1222.
14. Cullen C., Johnson D.S., Cook G. Re-admission rates within 28 days of total hip replacement. Ann R Coll Surg Engl 2006, 88:475.
15. Phillips C.B., Barrett J.A., Losina E., et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am 2003, 85-A:20.
16. Bozic K.J., Maselli J., Pekow P.S., et al. The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery. J Bone Joint Surg Am 2010, 92:2643.